Details for 2020734871

Up to date per 01.04.2026

Actions

Title / Product Name

EGFR-INHIBITOR ZUR BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020734871

EP Publication Number

3986897

E-Number

1605330

Language

PCT Number

EP20067076

Publication Date

27.04.2022 A

30.08.2023 B1

Registration Date

30.08.2023

AT Publication Date

15.09.2023

Application Date

19.06.2020

Registration Number

Priorities

21.06.2019

19181754

IPC

C07D 487/04 20060101AFI20201225BHEP

Maximum Duration of Protection

19.06.2040

Owner

F. Hoffmann-La Roche AGGrenzacherstrasse 124 4070 BaselCH

Representative

No representatives present

Inventor

DOLENTE, Cosimoc/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 BaselCH

GOERGLER, Annickc/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 BaselCH

HEWINGS, Davidc/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 BaselCH

JAESCHKE, Georgc/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 BaselCH

KUHN, Berndc/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 BaselCH

NAGEL, Yvonne, Alicec/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 BaselCH

OBST SANDER, Ulrikec/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 BaselCH

RICCI, Antonioc/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 BaselCH

RUEHER, Danielc/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 BaselCH

STEINER, Sandrac/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 BaselCH

Information about Fees